Researchers at DTU have patented a new invention that uses naturally produced substances from bifidobacteria in the gut to help lower the risk of allergies and asthma. Allergies and asthma are ...
Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...
The National Asthma Council Australia (NAC) has announced the appointment of Pharmaceutical Society of Australia (PSA) nominee Dr Amanda Cross to the board.
The National Asthma Council Australia (NAC) has announced the appointment of Pharmaceutical Society of Australia (PSA) nominee Dr Amanda Cross to the ...
Epinephrine is a commonly used agent for a variety of indications and clinical scenarios within the emergency department. It is commonly administered during cardiopulmonary arrest and serves as an ...
Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations ...
Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations ...
A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...
Rapid advances in modern medicine mean people are living longer than ever before - with new cures and treatments being discovered every day. But the journey to unravel the secrets of the human body ...
GSK plc GSK announced that the FDA has approved Exdensur (depemokimab-ulaa), an ultra-long-acting IL-5–targeting biologic, as an add-on maintenance treatment of severe asthma with an eosinophilic ...
Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype Approval based on SWIFT trials showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results